1. Home
  2. Analysis
  3. Cyclogyl
  4. Livostin

Cyclogyl and Livostin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cyclogyl and Livostin. Common interactions include anhedonia among females.

The phase IV clinical study analyzes what interactions people who take Cyclogyl and Livostin have. It is created by eHealthMe based on reports of 12 people who take Cyclogyl and Livostin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

12 people who take Cyclogyl and Livostin together, and have interactions are studied.

What is Cyclogyl?

Cyclogyl has active ingredients of cyclopentolate hydrochloride. eHealthMe is studying from 343 Cyclogyl users for its effectiveness, alternative drugs and more.

What is Livostin?

Livostin has active ingredients of levocabastine hydrochloride. eHealthMe is studying from 361 Livostin users for its effectiveness, alternative drugs and more.

Number of Cyclogyl and Livostin reports submitted per year:

Cyclogyl and Livostin drug interactions.

Common Cyclogyl and Livostin drug interactions by gender *:

female:

  1. Anhedonia
  2. Ankle fracture
  3. Disability
  4. Epicondylitis
  5. Herpes zoster
  6. Hypercholesterolaemia
  7. Hypertension
  8. Injury
  9. Intervertebral disc degeneration
  10. Intervertebral disc protrusion

male:

n/a

Common Cyclogyl and Livostin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anhedonia
  2. Ankle fracture
  3. Disability
  4. Epicondylitis
  5. Herpes zoster
  6. Hypercholesterolaemia
  7. Hypertension
  8. Injury
  9. Intervertebral disc degeneration
  10. Intervertebral disc protrusion

Common conditions people have *:

  1. High Blood Pressure: 12 people, 100.00%
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood): 11 people, 91.67%
  3. Anaemia (lack of blood): 11 people, 91.67%
  4. Type 2 Diabetes: 1 person, 8.33%
  5. Bipolar Disorder (mood disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclogyl and Livostin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cyclogyl and Livostin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclopentolate hydrochloride and levocabastine hydrochloride (the active ingredients of Cyclogyl and Livostin, respectively), and Cyclogyl and Livostin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cyclogyl and Livostin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.